142 related articles for article (PubMed ID: 30843318)
1. Radiotherapy for isolated recurrent epithelial ovarian cancer: A single institutional experience.
Komura N; Mabuchi S; Isohashi F; Yokoi E; Shimura K; Matsumoto Y; Kodama M; Tomimatsu T; Ogawa K; Kimura T
J Obstet Gynaecol Res; 2019 Jun; 45(6):1173-1182. PubMed ID: 30843318
[TBL] [Abstract][Full Text] [Related]
2. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
3. Weekly topotecan for recurrent ovarian, fallopian tube and primary peritoneal carcinoma: tolerability and efficacy study--the Israeli experience.
Safra T; Berman T; Yachnin A; Bruchim I; Meirovitz M; Barak F; Atlas I; Levy T; Rosengarten OS
Int J Gynecol Cancer; 2013 Mar; 23(3):475-80. PubMed ID: 23435437
[TBL] [Abstract][Full Text] [Related]
4. Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base.
Canaz E; Grabowski JP; Richter R; Braicu EI; Chekerov R; Sehouli J
Gynecol Oncol; 2019 Sep; 154(3):539-546. PubMed ID: 31230821
[TBL] [Abstract][Full Text] [Related]
5. Involved-field radiation therapy for selected cases of recurrent ovarian cancer.
Kim N; Chang JS; Kim SW; Kim GM; Lee JY; Kim YB
J Gynecol Oncol; 2019 Sep; 30(5):e67. PubMed ID: 31328453
[TBL] [Abstract][Full Text] [Related]
6. Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial.
Chang JS; Kim SW; Kim YJ; Kim JY; Park SY; Kim JH; Jang TK; Kim YB
Gynecol Oncol; 2018 Oct; 151(1):39-45. PubMed ID: 30146110
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes of recurrent epithelial ovarian cancer: experience from a Thailand northern tertiary care center.
Jansaka N; Suprasert P
Asian Pac J Cancer Prev; 2014; 15(24):10837-40. PubMed ID: 25605186
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative radiotherapy electron boost in advanced and recurrent epithelial ovarian carcinoma: a retrospective study.
Gao Y; Liu Z; Chen X; Luo W; Zhang L; Wang J
BMC Cancer; 2011 Oct; 11():439. PubMed ID: 21989202
[TBL] [Abstract][Full Text] [Related]
9. High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes.
Firat S; Murray K; Erickson B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):201-7. PubMed ID: 12909234
[TBL] [Abstract][Full Text] [Related]
10. Salvage chemotherapy in recurrent platinum-resistant or refractory epithelial ovarian cancer with Carboplatin and distearoylphosphatidylcholine pegylated liposomal Doxorubicin (lipo-dox®).
Khemapech N; Oranratanaphan S; Termrungruanglert W; Lertkhachonsuk R; Vasurattana A
Asian Pac J Cancer Prev; 2013; 14(3):2131-5. PubMed ID: 23679331
[TBL] [Abstract][Full Text] [Related]
11. Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy.
Yahara K; Ohguri T; Imada H; Yamaguchi S; Kawagoe T; Matsuura Y; Hachisuga T; Korogi Y
J Radiat Res; 2013 Mar; 54(2):322-9. PubMed ID: 23179378
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and toxicity between radiotherapy and chemotherapy in nodal and isolated nonnodal recurrence of ovarian cancer.
Lee M; Kim SW; Lee SH; Paek J; Yim GW; Kim GE; Kim S; Kim JH; Kim YT; Nam EJ
Int J Gynecol Cancer; 2011 Aug; 21(6):1032-9. PubMed ID: 21738040
[TBL] [Abstract][Full Text] [Related]
13. Radiation therapy is a treatment to be considered for recurrent epithelial ovarian cancer after chemotherapy.
Lee SW; Park SM; Kim YM; Kim YS; Choi EK; Kim DY; Kim JH; Nam JH; Kim YT
Tumori; 2011; 97(5):590-5. PubMed ID: 22158489
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes.
Skaznik-Wikiel ME; Lesnock JL; McBee WC; Beriwal S; Zorn KK; Richard SD; Krivak TC; Edwards RP
Int J Gynecol Cancer; 2012 Feb; 22(2):232-7. PubMed ID: 22080886
[TBL] [Abstract][Full Text] [Related]
15. A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer.
Krivak TC; Lele S; Richard S; Secord AA; Leath CA; Brower SL; Tian C; Moore RG
Am J Obstet Gynecol; 2014 Jul; 211(1):68.e1-8. PubMed ID: 24530815
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative electron beam radiotherapy (IOERT) in the management of recurrent ovarian malignancies.
Barney BM; Petersen IA; Dowdy SC; Bakkum-Gamez JN; Haddock MG
Int J Gynecol Cancer; 2011 Oct; 21(7):1225-31. PubMed ID: 21921800
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory therapy in refractory/recurrent ovarian cancer.
Chen CY; Lai CH; Yang LY; Tang YH; Chou HH; Chang CJ; Lin CT
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):143-9. PubMed ID: 25951718
[TBL] [Abstract][Full Text] [Related]
18. Patterns of recurrence and role of pelvic radiotherapy in ovarian clear cell adenocarcinoma.
Macrie BD; Strauss JB; Helenowski IB; Rademaker A; Schink JC; Lurain JR; Small W
Int J Gynecol Cancer; 2014 Nov; 24(9):1597-602. PubMed ID: 25275661
[TBL] [Abstract][Full Text] [Related]
19. Clinical observational study of conformal radiotherapy combined with topotecan chemotherapy in patients with platinum-resistant recurrent ovarian cancer.
Wei P; Zhang ZH; Li L; Du XL; Shan CP; Sheng XG
Genet Mol Res; 2015 Apr; 14(2):3833-42. PubMed ID: 25966153
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer.
Bozkaya Y; Doğan M; Umut Erdem G; Tulunay G; Uncu H; Arık Z; Demirci U; Yazıcı O; Zengin N
J Obstet Gynaecol; 2017 Jul; 37(5):649-654. PubMed ID: 28325092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
